Academic Journal
克拉屈滨治疗难治性朗格汉斯细胞组织细胞增生症一例并文献复习 ; Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review
| العنوان: | 克拉屈滨治疗难治性朗格汉斯细胞组织细胞增生症一例并文献复习 ; Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review |
|---|---|
| المؤلفون: | 谢瑶, 华瑛, 赵卫红, 孙青, 卢新天 |
| المساهمون: | 100034,北京大学第一医院儿科 |
| المصدر: | 万方 ; CSCD ; http://d.g.wanfangdata.com.cn/Periodical_zhek201504014.aspx |
| بيانات النشر: | 中华儿科杂志 |
| سنة النشر: | 2015 |
| المجموعة: | Peking University Institutional Repository (PKU IR) / 北京大学机构知识库 |
| مصطلحات موضوعية: | 组织细胞增多症, 复发, 克拉屈滨, Histiocytosis, Recurrence, Cladribine |
| الوصف: | 目的 探讨儿童难治、复发朗格汉斯细胞组织细胞增生症(LCH)的挽救治疗方法.方法 分析2012年6月北京大学第一医院儿科血液肿瘤病房收治的1例序贯应用数种化疗方案后多次复发的LCH患儿在应用克拉屈滨后病情得到控制的病例,并进行相关文献复习.结果 患儿男,生后3个月开始发病,评估为多系统(皮肤、多发骨骼、肺、肝脏等)伴危险器官受累,先后给予LCH-Ⅲ-Group Ⅰ、JLSG-96、DAL-HX90多种化疗方案,缓解后复发3次以上,直至6岁时给予克拉屈滨治疗,剂量为10 mg/(m2·d),连续应用4d,每28天为一疗程,第3～5个疗程联合应用阿糖胞苷[1g/(m2·d)],总疗程5个月,治疗1个疗程后病情缓解,治疗结束后病情完全控制,停药观察8个月病情仍稳定.以“克拉屈滨”“朗格汉斯细胞组织细胞增生症”和“难治性”为关键词,对中国期刊全文数据库(CNKI)、万方数据知识服务平台及生物医学文献检索数据库(PubMed)收录的论文进行检索,11篇文献研究显示克拉屈滨联合或不联合阿糖胞苷治疗难治性LCH,有效率为44％ ～ 100％,良好反应率22％～ 86％,剂量多为5～13 mg/(m2·d).克拉屈滨单药应用的不良反应主要为血液学毒性和感染,联合应用阿糖胞苷则毒副作用更加明显.结论 常规化疗药物对部分难治、复发LCH患儿的疗效有限时,可考虑应用克拉屈滨作为挽救治疗. ; Objective To investigate the salvage therapy for a child with refractory and (or) repeatedly-relapsed Langerhans cell histiocytosis.Method Data of a patient with Langerhans cell histiocytosis whose disease relapsed repeatedly treated with cladribine was collected and analyzed and the related literature was reviewed.Result The initial symptoms developed 3 months after his birth,multiple systems (skin,skeleton,lung,liver) were involved;he was sequentially treated with LCH-Ⅲ-Group Ⅰ,JLSG-96,DAL-HX90 chemotherapeutic regimens.The patient got relapses for more than 3 times,but the disease got completely controlled after being treated with cladribine when the patient was 6 years old.The dosage was 10 mg/(m2 · d) for 4 days,and one course lasted for 28 days,the third to fifth courses of treatment used Ara-c in combination,the whole treating time lasted for 5 months.The patient remained in persistent remission for 8 months since discontinuation of treatment." Langerhans cell histiocytosis refractory" " cladribine" were used as the key words to search in the data bases CNKI,Wanfangdata and Pubmed,11 articles were picked.According to the literature,the effective rate of cladribine in treatment of repeatedly relapsing Langerhans cell histiocytosis was 44％-100％,with a good response of 22％-86％,the dose was 5-13 mg/(m2 · d).The main side effects were hematological system damages and infection.Conclusion The effect of commonly used ... |
| نوع الوثيقة: | journal/newspaper |
| اللغة: | Chinese |
| تدمد: | 0578-1310 |
| Relation: | 中华儿科杂志.2015,53,(4),296-299.; 1287949; http://hdl.handle.net/20.500.11897/415447 |
| DOI: | 10.3760/cma.j.issn.0578-1310.2015.04.014 |
| الاتاحة: | https://hdl.handle.net/20.500.11897/415447 https://doi.org/10.3760/cma.j.issn.0578-1310.2015.04.014 |
| رقم الانضمام: | edsbas.1BCE6112 |
| قاعدة البيانات: | BASE |
| تدمد: | 05781310 |
|---|---|
| DOI: | 10.3760/cma.j.issn.0578-1310.2015.04.014 |